Pasar al contenido principal

UN MODELO PRE-CLINICO IN VITRO DE NOCICEPTORES HUMANOS PARA INVESTIGAR EL DIMORFISMO SEXUAL EN MIGRAÑA CRONICA Y RASTREAR CANDIDATOS A FARMACOS

RTI2018-097189-B-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of novel synthetic polyphenols: validation of antioxidant and vasculoprotective activities

  • Pérez de Vega, M. Jesús
  • Moreno-Fernández, Silvia
  • Pontes-Quero, Gloria María
  • González-Amor, María
  • Vázquez Lasa, Blanca
  • Sabater-Muñoz, Beatriz
  • Briones, Ana M.
  • Aguilar, María Rosa
  • Miguel, Marta
  • González-Muñiz, Rosario
Antioxidant compounds, including polyphenols, have therapeutic effects because of their anti-inflammatory, antihypertensive, antithrombotic and antiproliferative properties. They play important roles in protecting the cardiovascular and neurological systems, by having preventive or protective effects against free radicals produced by either normal or pathological metabolism in such systems. For instance, resveratrol, a well-known potent antioxidant, has a counteracting effect on the excess of reactive oxygen species (ROS) and has a number of therapeutic benefits, like anti-inflammatory, anti-cancer and cardioprotective activities. Based on previous work from our group, and on the most frequent OH substitutions of natural polyphenols, we designed two series of synthetically accessible bis-polyhydroxyphenyl derivatives, separated by amide or urea linkers. These compounds exhibit high antioxidant ability (oxygen radical absorbance capacity (ORAC) assay) and interesting radical scavenging activity (RSA) values (2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and α,α-diphenyl-β-picrylhydrazyl (DPPH) tests). Some of the best polyphenols were evaluated in two biological systems, endothelial cells (in vitro) and whole aorta (ex vivo), highly susceptible for the deleterious effects of prooxidants under different inflammatory conditions, showing protection against oxidative stress induced by inflammatory stimuli relevant in cardiovascular diseases, i.e., Angiotensin II and IL-1β. Selected compounds also showed strong in vivo antioxidant properties when evaluated in the model organism Saccharomyces cerevisiae., This research was funded by grants from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIU-FEDER) grant number RTI2018-097189-B-C22 to RGM, SAF2016-80305P to AMB, and CSIC grant number 2019E030 to RGM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators

  • Ximenis, Marta
  • Mulet, José
  • Sala, Salvador
  • Sala, Francisco
  • Criado Herrero, Manuel
  • González-Muñiz, Rosario
  • Pérez de Vega, M. Jesús
The α7 nicotinic acetylcholine receptor (α7 nAChR) is a ligand-gated ion channel that is involved in cognition disorders, schizophrenia, pain, and inflammation. Allosteric modulation of this receptor might be advantageous to reduce the toxicity in comparison with full agonists. Our previous results obtained with some hydroxy-chalcones, which were identified as positive allosteric modulators (PAMs) of α7 nAChR, prompted us to evaluate the potential of some structurally related naturally occurring flavonoids and curcuminoids and some synthetic curcumin analogues, with the aim of identifying new allosteric modulators of the α7 nAChR. Biological evaluation showed that phloretin, demethoxycurcumin, and bis-demethoxicurcuming behave as PAMs of α7 nAChR. In addition, some new curcumin derivatives were able to enhance the signal evoked by ACh; the activity values found for the tetrahydrocurcuminoid analog <b>23</b> were especially promising., This work was funded by grants from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIU-FEDER) grant number RTI2018-097189-B-C22 and CSIC grant number 2019E030 to RGM. BFU2008-02160 to MC and SAF2011-22802 to SS., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Natural Polyhydroxy Flavonoids, Curcuminoids and Synthetic Curcumin Analogs, as α7 nAChRs Positive Allosteric Modulators

  • Ximenis, Marta
  • Mulet, José
  • Sala, Salvador
  • Sala, Francisco
  • Criado Herrero, Manuel
  • González-Muñiz, Rosario
  • Pérez de Vega, M. Jesús
This work was funded by grants from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIU-FEDER) grant number RTI2018-097189-B-C22 and CSIC grant number 2019E030 to RGM. BFU2008-02160 to MC and SAF2011-22802 to SS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacological Approaches for the Modulation of the Potassium Channel KV4.x and KChIPs

  • Cercós, Pilar
  • Peraza, Diego A.
  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Aziz-Nignan, A.
  • Arrechaga-Estévez, D.
  • Beato, E.
  • Peña-Acevedo, E.
  • Albert, Armando
  • Martín-Martínez, Mercedes
  • Valenzuela, Carmen
  • Gutiérrez-Rodríguez, Marta
Ion channels are macromolecular complexes present in the plasma membrane and intracellular organelles of cells. Dysfunction of ion channels results in a group of disorders named channelopathies, which represent an extraordinary challenge for study and treatment. In this review, we will focus on voltage-gated potassium channels (KV), specifically on the KV4-family. The activation of these channels generates outward currents operating at subthreshold membrane potentials as recorded from myocardial cells (ITO, transient outward current) and from the somata of hippocampal neurons (ISA). In the heart, KV4 dysfunctions are related to Brugada syndrome, atrial fibrillation, hypertrophy, and heart failure. In hippocampus, KV4.x channelopathies are linked to schizophrenia, epilepsy, and Alzheimer’s disease. KV4.x channels need to assemble with other accessory subunits () to fully reproduce the ITO and ISA currents. Subunits affect channel gating and/or the traffic to the plasma membrane, and their dysfunctions may influence channel pharmacology. Among KV4 regulatory subunits, this review aims to analyze the KV4/KChIPs interaction and the effect of small molecule KChIP ligands in the A-type currents generated by the modulation of the KV4/KChIP channel complex. Knowledge gained from structural and functional studies using activators or inhibitors of the potassium current mediated by KV4/KChIPs will better help understand the underlying mechanism involving KV4-mediated-channelopathies, establishing the foundations for drug discovery, and hence their treatments., This research was funded by Ministerio de Ciencia e Innovación (MICIU) Spain SAF2016- 75021-R and PID2019-104366RB-C21 (to CV), RTI2018-097189-B-C22 (to MMM), PID2019-104366RBC22 (to MG-R); the Instituto de Salud Carlos III CIBERCV program CB/11/00222 (to CV); and the Consejo Superior de Investigaciones Científicas grants: PIE 201820E104, 2019AEP148 (to CV), and 201880E109 (to MMM and MG-R). The cost of this publication was paid in part by funds from the European Fund for Economic and Regional Development (FEDER). PC held a postgraduate FPI fellowship from the Spanish Ministry of Economy, Industry, and Competitivity (MINECO). DAP held CSIC contracts. AdB-B holds a MICIU predoctoral contract (BES-2017-080184). PGS holds a MICIU predoctoral contract FPU2017/02731. AAN, DAE, EB, and EPA were sponsored by CUNY Research Scholars Program (CRSP) and Collegiate Science Technology Entry Program (CSTEP). YR is grateful to the Hostos Office of Academic Affairs for providing travel awards and the OpenEye Scientific Software for providing free academic licenses. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators

  • Martín-Martínez, Mercedes
  • González-Muñiz, Rosario
  • Algar, Sergio
Modulation of interactome networks, essentially protein-protein interactions (PPIs), might representvaluable therapeutic approaches to different pathological conditions. Since a high percentage of PPIs aremediated bya-helical structures at the interacting surface, the development of compounds able toreproduce the amino acid side-chain organization ofa-helices (e.g. stabilizeda-helix peptides andb-derivatives, proteomimetics, anda-helix small-molecule mimetics) focuses the attention of differentresearch groups. This appraisal describes the recent progress in the non-peptidea-helix mimeticsfield,which has evolved from single-face to multi-face reproducing compounds and from oligomeric tomonomeric scaffolds able to bear different substituents in similar spatial dispositions as the side-chainsin canonical helices. Grouped by chemical structures, the review contemplates terphenyl-like molecules,oligobenzamides and heterocyclic analogues, benzamide-amino acid conjugates and non-oligomericsmall-molecules mimetics, among others, and their effectiveness to stabilize/disrupt therapeuticallyrelevant PPIs. The X-ray structures of a couple of oligomeric peptidomimetics and of some small-molecules complexed with the MDM2 protein, as well as the state of the art on their development inclinical trials, are also remarked. The discovery of a continuously increasing number of new disease-relevant PPIs could offer future opportunities for these and other forthcominga-helix mimetics., This research was funded by grants from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIU-FEDER), grantnumber RTI2018-097189-B-C22 to RGM, and CSIC grant numbers201880E109 to MMM and 2019E030 to RGM.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of KV4.3-KChIP2 Channels by IQM-266: Role of DPP6 and KCNE2

  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Merinero, Yaiza G.
  • Cercós, Pilar
  • Izquierdo García, Carolina
  • Daniel-Mozo, Miguel
  • Marín-Olivero, Irene
  • Pérez-Lara, Ángel
  • González-Vera, Juan A.
  • Orte, Angel
  • Albert, Armando
  • Martín-Martínez, Mercedes
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
The transient outward potassium current (Itof) is generated by the activation of KV4 chan- nels assembled with KChIP2 and other accessory subunits (DPP6 and KCNE2). To test the hypothesis that these subunits modify the channel pharmacology, we analyzed the electrophysiological effects of (3-(2-(3-phenoxyphenyl)acetamido)-2-naphthoic acid) (IQM-266), a new KChIP2 ligand, on the currents generated by KV4.3/KChIP2, KV4.3/KChIP2/DPP6 and KV4.3/KChIP2/KCNE2 channels. CHO cells were transiently transfected with cDNAs codifying for different proteins (KV4.3/KChIP2, KV4.3/KChIP2/DPP6 or KV4.3/KChIP2/KCNE2), and the potassium currents were recorded using the whole-cell patch-clamp technique. IQM-266 decreased the maximum peak of KV4.3/KChIP2, KV4.3/KChIP2/DPP6 and KV4.3/KChIP2/KCNE2 currents, slowing their time course of inactivation in a concentration-, voltage-, time- and use-dependent manner. IQM-266 produced an increase in the charge in KV4.3/KChIP2 channels that was intensified when DPP6 was present and abolished in the presence of KCNE2. IQM-266 induced an activation unblocking effect during the applica- tion of trains of pulses to cells expressing KV4.3/KChIP2 and KV4.3/KChIP2/KCNE2, but not in KV4.3/KChIP2/DPP6 channels. Overall, all these results are consistent with a preferential IQM-266 binding to an active closed state of Kv4.3/KChIP2 and Kv4.3/KChIP2/KCNE2 channels, whereas in the presence of DPP6, IQM-266 binds preferentially to an inactivated state. In conclusion, DPP6 and KCNE2 modify the pharmacological response of KV4.3/KChIP2 channels to IQM-266., This publication is the results of the: Grants SAF2016-75021-R (to C.V.), RTI2018-097189-B- C22 (to M.M.-M.) and BIO2017-89523-R (to A.A.) funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; Grants PID2019-104366RB-C21 (to C.V.), PID2019-104366RB- C22 (to M.G.-R.), PID2020-114256RB-I00 (to A.O. and J.A.G.-V.), PID2020-119805RB-I00 (to A.A.) funded by MCIN/AEI/10.13039/501100011033; Grant A-FQM-386-UGR20 funded by FEDER/Junta de Andalucía-Consejería de Transformación Económica, Industria, Conocimiento (to J.A.G.-V.); Grant CB/11/00222 funded by Instituto de Salud Carlos III CIBERCV (to C.V.); Grants PIE202180E073 (to M.M.-M. and M.G.-R.), PIE201820E104 and 2019AEP148 (to C.V.) funded by Consejo Superior de Investigaciones Científicas. Grants BES-2017-080184 (to A.d.B.-B.), BES-2010-036573 (to P.C.), PRE2018- 083280 (to M.D.-M.) and RYC2018-023837-I (to A.P.-L.) funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”; Grant FPU17/02731 (to P.G.S.) funded by Ministerio de Ciencia e Innovación., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Electrophysiological effects of IQM-266 on Itof. Role of cardiac beta subunits

  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Cercós, Pilar
  • Izquierdo García, Carolina
  • Martín-Martínez, Mercedes
  • Delgado, Carmen
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Trabajo presentado en el VIII Congreso Red Española de Canales Sónicos, celebrado en Alicante (España) del 24 al 27 de mayo de 2022., The transient outward potassium current (Itof), responsible for the repolarization of cardiac action potential, is generated by the activation of KV4 channels assembled with KChIP2 and other accessory subunits, such as DPP6 and KCNE2. To test the hypothesis that these subunits modify 18 VIII Congreso Red Española de Canales Iónicos the pharmacological response of the channel, we have analyzed the electrophysiological efects of IQM-266 on the currents generated by KV4.3/KChIP2, KV4.3/KChIP2/DPP6, KV4.3/KChIP2/KCNE2 channels and on the total I K and I tof in cardiac myocytes. CHO cells were transiently transfected (KV4.3/KChIP2, KV4.3/KChIP2/DPP6 or KV4.3/KChIP2/KCNE2), and the potassium currents were recorded using the whole-cell patch-clamp technique. In mice cardiac myocytes, potassium currents were recorded by using the perforated patch-clamp technique. Our results indicate that IQM-266 exerts an activating efect on the I K and I tof peak amplitude in cardiac myocytes. To decipher whichbeta subunits were involved in these efects, IQM-266 was studied in CHO cells transfected with the above-mentioned cDNAs. IQM-266, at 3 μM, induced an increase in the KV4.3/KChIP2 current charge, which augmented in the presence of DPP6, whereas it was abolished when KCNE2 was expressed. However, IQM-266 decreased the peak amplitude in transfected cells. In this study we concluded that: i) IQM-266 is a new activator of the I tof in mice cardiac myocytes, ii) DPP6 and KCNE2 modify the pharmacological response of KV4.3/KChIP2 channels to IQM-266, and iii) the presence of either DPP6 or KCNE2 is not enough to reproduce the activator efect observed when IQM-266 was tested on Ito recorded from mouse ventricular myocytes., Grants SAF2016-75021-R, RTI2018-097189-B-C22 funded by MCIN/AEI/10.13039/501100011033 and by ¿ERDF A way of making Europe¿; Grants PID2019-104366RB-C21, PID2019-104366RB-C22, PID2020-113238RB-I00 funded by MCIN/AEI/ 10.13039/501100011033; Grant CB/11/00222 funded by ISCIII CIBERCV; Grants PIE202180E073 and 2019AEP148 funded by CSIC. Grants BES-2017-080184, BES-2010-036573 and FPU17/02731 funded by MCIN/AEI/10.13039/501100011033 and by ¿ESF Investing in your future¿.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel 1,4-Dihydropyridine Derivatives as Mineralocorticoid Receptor Antagonists

  • Pérez-Gordillo, Felipe L.
  • Serrano-Morillas, Natalia
  • Acosta-García, Luz M.
  • Aranda, M. Teresa
  • Passeri, D.
  • Pellicciari, Roberto
  • Pérez de Vega, M. Jesús
  • González-Muñiz, Rosario
  • Alvarez de la Rosa, Diego
  • Martín-Martínez, Mercedes
The mineralocorticoid receptor (MR) belongs to the steroid receptor subfamily of nuclear receptors. MR is a transcription factor key in regulating blood pressure and mineral homeostasis. In addition, it plays an important role in a broad range of biological and pathological conditions, greatly expanding its interest as a pharmacological target. Non-steroidal MR antagonists (MRAs) are of particular interest to avoid side effects and achieve tissue-specific modulation of the receptor. The 1,4-dihydropyridine (1,4-DHP) ring has been identified as an appropriate scaffold to develop non-steroidal MRAs. We report the identification of a novel series of 1,4-DHP that has been guided by structure-based drug design, focusing on the less explored DHP position 2. Interestingly, substituents at this position might interfere with MR helix H12 disposition, which is essential for the recruitment of co-regulators. Several of the newly synthesized 1,4-DHPs show interesting properties as MRAs and have a good selectivity profile. These 1,4-DHPs promote MR nuclear translocation with less efficiency than the natural agonist aldosterone, which explains, at least in part, its antagonist character. Molecular dynamic studies are suggestive of several derivatives interfering with the disposition of H12 in the agonist-associated conformation, and thus, they might stabilize an MR conformation unable to recruit co-activators., This research was funded by grants BFU2016-78374-R and PID2019-105339RB-I00 to D.A.d.l.R., funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe”. RTI-2018-097189-B-C22, PID2021-126423OB-C22 and CSIC (202180E073) to MMM. N.S.-M. was supported by fellowship BES-2014-068280, funded by MCIN/AEI/10.13039/501100011033 and “ESF Investing in your future”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications

  • Ciaglia, Tania
  • Vestuto, Vincenzo
  • Bertamino, Alessia
  • González-Muñiz, Rosario
  • Gómez-Monterrey, Isabel
The transient melastatin receptor potential (TRPM) ion channel subfamily functions as cellular sensors and transducers of critical biological signal pathways by regulating ion homeostasis. Some members of TRPM have been cloned from cancerous tissues, and their abnormal expressions in various solid malignancies have been correlated with cancer cell growth, survival, or death. Recent evidence also highlights the mechanisms underlying the role of TRPMs in tumor epithelial-mesenchymal transition (EMT), autophagy, and cancer metabolic reprogramming. These implications support TRPM channels as potential molecular targets and their modulation as an innovative therapeutic approach against cancer. Here, we discuss the general characteristics of the different TRPMs, focusing on current knowledge about the connection between TRPM channels and critical features of cancer. We also cover TRPM modulators used as pharmaceutical tools in biological trials and an indication of the only clinical trial with a TRPM modulator about cancer. To conclude, the authors describe the prospects for TRPM channels in oncology., This work was supported by grants from Regione CampaniaPON Campania FESR 2014-2020 “Combattere la resistenza tumorale: piattaforma integrate multidisciplinare per un approccio tecnologico innovativo alle oncoterapie-Campania Oncoterapie (Project N. B61G18000470007), and Spanish Ministry of Science and Innovation (RTI2018-097189B-C22 and PID2021-126423OB-C22)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure–Activity Relationships and Antiallodynic Activity

  • Martín-Escura, Cristina
  • Bonache, M. Ángeles
  • Medina, Jessy A.
  • Medina-Peris, Alicia
  • Andrés-López, Jorge De
  • González-Rodríguez, Sara
  • Kerselaers, Sara
  • Fernández-Ballester, Gregorio
  • Voets,Thomas
  • Ferrer-Montiel, Antonio
  • Fernández-Carvajal, Asia
  • González-Muñiz, Rosario
The protein transient receptor potential melastatin type 8 (TRPM8), a non-selective, calcium (Ca2+)-permeable ion channel is implicated in several pathological conditions, including neuropathic pain states. In our previous research endeavors, we have identified β-lactam derivatives with high hydrophobic character that exhibit potent and selective TRPM8 antagonist activity. This work describes the synthesis of novel derivatives featuring C-terminal amides and diversely substituted N′-terminal monobenzyl groups in an attempt to increase the total polar surface area (TPSA) in this family of compounds. The primary goal was to assess the influence of these substituents on the inhibition of menthol-induced cellular Ca2+ entry, thereby establishing critical structure–activity relationships. While the substitution of the tert-butyl ester by isobutyl amide moieties improved the antagonist activity, none of the N′-monobencyl derivatives, regardless of the substituent on the phenyl ring, achieved the activity of the model dibenzyl compound. The antagonist potency of the most effective compounds was subsequently verified using Patch-Clamp electrophysiology experiments. Furthermore, we evaluated the selectivity of one of these compounds against other members of the transient receptor potential (TRP) ion channel family and some receptors connected to peripheral pain pathways. This compound demonstrated specificity for TRPM8 channels. To better comprehend the potential mode of interaction, we conducted docking experiments to uncover plausible binding sites on the functionally active tetrameric protein. While the four main populated poses are located by the pore zone, a similar location to that described for the N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)-benzamide (AMTB) antagonist cannot be discarded. Finally, in vivo experiments, involving a couple of selected compounds, revealed significant antinociceptive activity within a mice model of cold allodynia induced by oxaliplatin (OXA)., This research was funded by funded by MCIN/AEI/10.13039/501100011033 “FEDER, Una manera de hacer Europa: grant numbers RTI2018-097189-B-C21 (to A.F.-M. and A.F.-C.), RTI2018-097189-B-C22 (to R.G.-M.), PID2021-126423OB-C21 (to A.F.-M. and A.F.-C.) and PID2021-126423OB-C21 (to R.G.-M.); Generalitat Valenciana: PROMETEO/2021/031 (to A.F.-M.); and Comunidad de Madrid: IND2017/BMD7673 (to R.G.-M.), Peer reviewed